Gossamer Bio Inc stock is traded at $10.72, with a volume of 191,354. It is down -4.54% in the last 24 hours and up +11.90% over the past month. Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Previous Close:
$11.23
Open:
$11.02
24h Volume:
191,354
Relative Volume:
0.96
Market Cap:
$65.57M
Revenue:
$55.54M
Net Income/Loss:
-$180.40M
P/E Ratio:
-
EPS:
-$0.7877
Net Cash Flow:
-$170.32M
1W Performance:
-2.28%
1M Performance:
+11.90%
6M Performance:
-37.76%
1Y Performance:
-95.69%
1-Day Range:
$10.65$11.60
1-Week Range:
$10.22$11.85
52-Week Range:
$8.29$309.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Name
Gossamer Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 684-1300Address
3115 MERRYFIELD ROW, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS